Basal cell carcinoma of skin of left lower limb, including hip
ICD-10 C44.719 is a billable code used to indicate a diagnosis of basal cell carcinoma of skin of left lower limb, including hip.
Basal cell carcinoma (BCC) is the most common form of skin cancer, arising from the basal cells in the epidermis. This specific code, C44.719, refers to BCC located on the skin of the left lower limb, including the hip area. BCC is primarily associated with prolonged sun exposure, which leads to DNA damage in skin cells. Clinically, BCC may present as a pearly or waxy bump, a flat, flesh-colored lesion, or a scar-like area. The diagnosis is typically confirmed through a biopsy. Treatment often involves surgical excision, Mohs micrographic surgery, or topical chemotherapy, depending on the size and location of the tumor. Surgical margins are crucial in BCC management to ensure complete removal and minimize recurrence. Reconstruction may be necessary post-excision, especially in cosmetically sensitive areas like the face or limbs, to restore skin integrity and function. Regular follow-up is essential due to the potential for new lesions, particularly in patients with a history of skin cancer.
Detailed descriptions of lesion characteristics, biopsy results, and treatment plans.
Diagnosis and treatment of BCC, follow-up for skin cancer surveillance, and management of multiple skin lesions.
Ensure accurate coding of the specific site and size of the carcinoma, as well as any reconstruction performed.
Comprehensive treatment plans, including surgical notes and pathology reports.
Management of advanced BCC cases, coordination of care for patients with multiple skin cancers.
Documentation should reflect the multidisciplinary approach to treatment and any adjuvant therapies used.
Used for excision of BCC with reconstruction.
Surgical notes detailing the procedure and margins.
Dermatology must document the extent of the excision and any reconstruction performed.
Surgical margins are critical in BCC treatment to ensure complete removal of cancerous cells and reduce the risk of recurrence. Clear margins indicate that the cancer has been fully excised.
